Chao Center to close; replacement Seromycin maker required
The Chao Center for Industrial research and contract manufacturing is to close this year after failing to become a self sustaining enterprise.
Archives for April 27, 2010
Appointments at Roche, AVI BioPharma, Amgen and Delcath Systems – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Roche, AVI BioPharma, Amgen and Delcath Systems.
FDA: Teva response to Cali plant problems insufficient
The US FDA says Teva Pharmaceutical Industries’ plan to fix cGMP violations observed at its plant in Irving, California “lack sufficient corrective actions.”
L’Oreal says sale of its stake in Sanofi-aventis is not imminent
L’Oreal says that it is in ‘no hurry’ to sell off the 8.97 per cent stake in France-based consumer health care and pharmaceuticals player Sanofi-aventis.
CROs & eClinical firms post generally positive results
The CRO and eClinical results period is underway, with Icon, Parexel, Phase Forward and OmniComm publishing generally positive financials in the past two days.
Mitsubishi Tanabe CEO quits JPMA role after manufacturing ban
Manufacturing problems at Mitsubishi Tanabe Pharma (MTP) have forced CEO Michihiro Tsuchiya to relinquish his vice presidency of the Japanese Pharmaceutical Manufacturers Association (JPMA).